Literature DB >> 24937450

Protective effects of Sapindus mukorossi Gaertn against fatty liver disease induced by high fat diet in rats.

Qiuxian Peng1, Qin Zhang2, Wei Xiao2, Meng Shao2, Qin Fan2, Hongwei Zhang2, Yukai Zou3, Xin Li4, Wenxue Xu2, Zhixian Mo2, Hongbing Cai5.   

Abstract

OBJECTIVES: Study the effects of alcohol extract of Sapindus mukorossi Gaertn (AESM) on the metabolism of blood fat, morphology of fenestrated liver sinusoidal endothelial cells (LSEC), and the ultrastructure of liver cells of the rats with non-alcoholic fatty liver disease (NAFLD).
METHODS: Divide SD rats into control group, model group, simvastatin (7.2 mg/kg) group, and S.mukorossi Gaertn group with high dosage (0.5 g/kg), moderate dosage (0.1 g/kg), and low dosage (0.05 g/kg). After feeding with fat-rich nutrients for 3 weeks and establishing the model of hepatic adipose, conduct intragastric administration and provide the rats with fat-rich nutrients at the same time. At the 43rd day, take blood sample and measure aminotransferase and different indexes of blood fat; take hepatic tissue for pathological section, and observe the hepatic morphological patterns under light microscope; obtain and fix the hepatic tissue after injecting perfusate into the body, and observe the changes of fenestrated LSEC under scanning electron microscope; observe the ultrastructure of liver cells under transmission electron microscope.
RESULTS: High-dosage alcohol extracts of S.mukorossi Gaertn can alleviate the AST, ALT, TC, TG, LDL, γ-GT, and ALP level, as well as raise the HDL and APN level in the serum of NAFLD-rat model. In addition, through the observation from light microscope and electron microscopes, the morphology of the hepatic tissue and liver cells as well as the recovery of the fenestrated LSEC in the treatment group has become normal.
CONCLUSIONS: Alcohol extracts of S.mukorossi Gaertn can regulate the level of blood fat and improve the pathological changes of the hepatic tissues in NAFLD-rat model, which demonstrates the effects of down-regulating fat level and protecting liver.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Blood fat; Fenestrated LSEC; Non-alcohol fatty liver disease (NAFLD); Sapindus mukorossi Gaertn

Mesh:

Substances:

Year:  2014        PMID: 24937450     DOI: 10.1016/j.bbrc.2014.06.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease.

Authors:  Maria Catalina Hernandez-Rodas; Rodrigo Valenzuela; Luis A Videla
Journal:  Int J Mol Sci       Date:  2015-10-23       Impact factor: 5.923

Review 2.  Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease.

Authors:  Xue-Kai Wang; Zong-Gen Peng
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

Review 3.  Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review.

Authors:  Narjes Nasiri-Ansari; Theodoros Androutsakos; Christina-Maria Flessa; Ioannis Kyrou; Gerasimos Siasos; Harpal S Randeva; Eva Kassi; Athanasios G Papavassiliou
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

4.  Metabolomics analysis of the soapberry (Sapindus mukorossi Gaertn.) pericarp during fruit development and ripening based on UHPLC-HRMS.

Authors:  Yuanyuan Xu; Yuan Gao; Zhong Chen; Guochun Zhao; Jiming Liu; Xin Wang; Shilun Gao; Duanguang Zhang; Liming Jia
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

Review 5.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.